https://seer.cancer.gov/oncologytoolbox/canmed/hcpcs/1687/
J9382 Zenocutuzumab-zbco - CanMED: HCPCS
CanMED: HCPCS. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
hcpcs
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-bizengri-zenocutuzumab-zbco-treatment-adults-advanced
FDA D.I.S.C.O. Burst Edition: FDA approval of Bizengri (zenocutuzumab-zbco) for Treatment of adults...
FDA D.I.S.C.O. Burst Edition: FDA approval of Bizengri (zenocutuzumab-zbco) for Treatment of adults with advanced unresectable or metastatic pancreatic...